← All candidates
One insider buy in the last year — $20.3K in all.
3 filings on record.
NSRXNasus Pharma Ltd
NYSE American · Healthcare · $39.88M
$3.40
+1.64% · Sep 11
One insider buy in the last year — $20.3K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy
▸ hover a marker for the filing · drag to zoom · 3 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$39.88M
Float
5.5M
47% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Executive Officer
Teleman Dan Benjamin
Bought $20.3K on Jun 17 — 6,550 sh @ $3.10, held direct, 4.0% of their stake.
First Form 4 on file
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
The file stays open
3 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice